Articles

Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia

Perelman University of Pennsylvania School of Medicine, Philadelphia, PA, USA
University of Connecticut Health Center, Farmington, CT, USA
Hematology Project Foundation, Vicenza, Italy;San Bortolo Hospital, Vicenza, Italy
St George Hospital/University of New South Wales, Sydney, Australia
Medical University of Innsbruck, Austria
Barts and the London School of Medicine and Dentistry, London, UK
Texas Oncology and US ONCOLOGY Research, San Antonio, TX
Centro Médico Nacional La Raza, Mexico City, Mexico
Amgen Limited, Uxbridge, UK
Amgen Inc., Thousand Oaks, CA, USA
Amgen Inc., Thousand Oaks, CA, USA
Vol. 102 No. 8 (2017): August, 2017 https://doi.org/10.3324/haematol.2016.161968